Abhishek Srivastava
Plus aucun poste en cours
Fortune : 93 $ au 30/04/2024
Historique de carrière de Abhishek Srivastava
Anciens postes connus de Abhishek Srivastava
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 04/08/2022 | 01/10/2023 |
| ATHENEXPAR | Corporate Officer/Principal | - | - |
Formation de Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Bourse
- Insiders
- Abhishek Srivastava
- Expérience